Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...

Alcon AG plans to acquire Lumithera Inc., adding its photobiomodulation (PBM) device designed to treat early and intermediate ...

This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...

Patients, especially contact lens wearers, may develop microplastic toxicity and exhibit symptoms such as dry eye, a study ...

Topline data were announced from a phase 3 trial evaluating ST-100 (vezocolmitide) ophthalmic solution for the treatment of dry eye disease (DED). ST-100 is a novel collagen mimetic peptide designed ...

Objectives To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). Methods We conducted a systematic search of the literature on PubMed, EMBASE and the ...

Rose water, valued for centuries, offers several eye care benefits due to its anti-inflammatory, antimicrobial, and hydrating properties. It can relie ...

Blood biologics can be used for mild to advanced dry eye. Autologous serum, platelet-rich plasma and plasma-rich growth factors provide natural treatment options. MINNEAPOLIS — Blood biologics ...

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study ...

Per FDA agreement, the only new clinical data included in the resubmitted NDA were from the recently completed dry eye chamber trial, which achieved the primary endpoint.